Efficacy of abrocitinib and dupilumab on chronic hand eczema in patients with moderate-to-severe atopic dermatitis: a prespecified exploratory analysis of the phase 3 JADE DARE study.
- DOI
- 10.1016/j.jaad.2026.08.108
- Published
- 2026-09-02
- Container
- J Am Acad Dermatol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2026.08.108,
title = {Efficacy of abrocitinib and dupilumab on chronic hand eczema in patients with moderate-to-severe atopic dermatitis: a prespecified exploratory analysis of the phase 3 JADE DARE study.},
author = {Bissonnette R and Shi V and Giménez-Arnau A and Crépy MN and Schuttelaar MLA and Lazariciu I and Bratt T and Selfridge A and Encinas G and Koppensteiner H.},
year = {2026},
journal = {J Am Acad Dermatol},
doi = {10.1016/j.jaad.2026.08.108},
url = {https://doi.org/10.1016/j.jaad.2026.08.108}
}RIS
TY - JOUR TI - Efficacy of abrocitinib and dupilumab on chronic hand eczema in patients with moderate-to-severe atopic dermatitis: a prespecified exploratory analysis of the phase 3 JADE DARE study. AU - Bissonnette R AU - Shi V AU - Giménez-Arnau A AU - Crépy MN AU - Schuttelaar MLA AU - Lazariciu I AU - Bratt T AU - Selfridge A AU - Encinas G AU - Koppensteiner H. PY - 2026 JO - J Am Acad Dermatol DO - 10.1016/j.jaad.2026.08.108 UR - https://doi.org/10.1016/j.jaad.2026.08.108 ER -
APA
R, B., V, S., A, G., MN, C., MLA, S., I, L., T, B., A, S., G, E., & H., K. (2026). Efficacy of abrocitinib and dupilumab on chronic hand eczema in patients with moderate-to-severe atopic dermatitis: a prespecified exploratory analysis of the phase 3 JADE DARE study.. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2026.08.108
Source records
- europe-pmc · retrieved 2026-09-26T17:09:27.135Z